Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Journal of Cellular Physiology|January 13, 2017
Cancer Stem Cells (CSCs) in melanoma: There's smoke, but is there fire?Constance E BrinckerhoffNature Reviews. Molecular Cell Biology|May 8, 2002
Matrix metalloproteinases: a tail of a frog that became a princeConstance E Brinckerhoff, Lynn M MatrisianArthritis Research & Therapy|January 14, 2010
The 'RASor's' edge: Ras proteins and matrix destruction in arthritisAdam C Schmucker, Constance E BrinckerhoffThe American Journal of Pathology|November 8, 2008
Matrix metalloproteinase-1 and thrombin differentially activate gene expression in endothelial cells via PAR-1 and promote angiogenesisJessica S Blackburn, Constance E BrinckerhoffMolecular Cancer|December 5, 2006
Tumor cell invasion of von Hippel Lindau renal cell carcinoma cells is mediated by membrane type-1 matrix metalloproteinaseBrenda L Petrella, Constance E BrinckerhoffJournal of Cellular Physiology|July 27, 2007
Signal transduction and cell-type specific regulation of matrix metalloproteinase gene expression: can MMPs be good for you?Matthew P Vincenti, Constance E BrinckerhoffCancer Biology & Therapy|June 2, 2009
PTEN suppression of YY1 induces HIF-2 activity in von-Hippel-Lindau-null renal-cell carcinomaBrenda L Petrella, Constance E BrinckerhoffArthritis Research|May 16, 2002
Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factorsMatthew P Vincenti, Constance E BrinckerhoffOncogene|December 14, 2004
Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2 alpha in von Hippel-Lindau renal cell carcinomaBrenda L Petrella, Jouko Lohi, Constance E BrinckerhoffCurrent Opinion in Investigational Drugs (London, England : 2000)|December 3, 2004
Selective retinoic acid receptor ligands for rheumatoid arthritisBlake C Beehler, Constance E Brinckerhoff, Jacek OstrowskiPageof 4